Business · 30/01/2002

FDA Withdraws Guidance on Professional Flexible Labeling of Antimicrobial Drugs

The Food and Drug Administration (FDA) is withdrawing a guidance document for the industry, titled 'Professional Flexible Labeling of Antimicrobial Drugs,' due to outdated thinking on the development of professional flexible labeling for therapeutic veterinary prescription antimicrobial drugs. The FDA plans to create a new document on this topic.